Gene therapy biotech MeiraGTx sets terms for $75 million IPO – Nasdaq
Nasdaq |
Gene therapy biotech MeiraGTx sets terms for $75 million IPO
Nasdaq MeiraGTx Holdings, which is developing gene therapies for disorders of the eye and salivary gland, announced terms for its IPO on Tuesday. The New York, NY-based company plans to raise $75 million by offering 5.0 million shares at a price range of $14 … |
